ITIL-306 in Advanced Solid Tumors
Instil Bio
Instil Bio
Instituto do Cancer do Estado de São Paulo
858 Therapeutics, Inc.
Myeloid Therapeutics
Novartis
MacroGenics
Nurix Therapeutics, Inc.
Xencor, Inc.
Toray Industries, Inc
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Klus Pharma Inc.
Theratechnologies
SOLTI Breast Cancer Research Group
Stanford University
Cybrexa Therapeutics
Carisma Therapeutics Inc
23andMe, Inc.
Salubris Biotherapeutics Inc
Hoffmann-La Roche
pharmaand GmbH
Eli Lilly and Company
Canadian Cancer Trials Group
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Eastern Cooperative Oncology Group
Xencor, Inc.
MacroGenics
Gilead Sciences
Novartis
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
University of Maryland, Baltimore
City of Hope Medical Center
Pfizer
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Beth Israel Deaconess Medical Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
University of Southern California
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals